Immunomedics Inc (NASDAQ:IMMU)

40.00
Delayed Data
As of 3:59pm ET
 -0.95 / -2.32%
Today’s Change
8.80
Today|||52-Week Range
44.91
+89.04%
Year-to-Date
Biotech Bonanza - Second Half Outlook
Jul 28 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close40.95
Today’s open43.00
Day’s range39.78 - 41.47
Volume62,848
Average volume (3 months)4,414,208
Market cap$9.9B
Data as of 3:59pm ET, 08/11/2020

Growth & Valuation

Earnings growth (last year)-10.31%
Earnings growth (this year)+39.29%
Earnings growth (next 5 years)-73.37%
Revenue growth (last year)--
P/E ratioNM
Price/Sales13,887.90
Price/Book33.98

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+3.72+1.44%
NVAXNovavax Inc-29.31-16.42%
NBIXNeurocrine Bioscienc...+0.46+0.41%
EBSEmergent BioSolution...-8.17-6.28%
Data as of 5:47pm ET, 08/11/2020

Financials

Next reporting dateOctober 29, 2020
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$295.0K
Annual profit (last year)-$357.2M
Net profit margin-121,081.36%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Morris Plains, New Jersey

Forecasts